Here’s what’s different about Slinda, the single-hormone contraceptive just added to the PBS
- Written by Nial Wheate, Professor, School of Natural Sciences, Macquarie University
areeya_ann/ShutterstockFrom May 1, the oral contraceptive Slinda (drospirenone) will be listed on the Pharmaceutical Benefits Scheme (PBS). This means the price will drop for the more than 100,000 Australian women who currently use it – from around $A320 a year to around $94.
It’s the third contraceptive pill the federal government has...
Daily Bulletin
